Member Info for gixer

No mention of filling the position then.

Bioactive food components and their inhibitory actions in multiple platelet pathways

Includes Fruitflow.

https://onlinelibrary.wiley.com/doi/10.1111/jfbc.14476?fbclid=IwAR29Ml_lGuMJMlp0dQXPuMFqUh9LCmjAA_RCTevOopY2V80o_ZqRaai8LFw

My thoughts were that DSM might still want a board member at PXS as they still have a Premix and Market-Ready Solutions supply agreement with us and also the new partnership that has been agreed relating to the gut microbiome patent. Not forgetting the 143,769,230 shares DSM-V still hold.
"We aim to take an active role in startup activities at the board level"
https://www.venturing.dsm.com/en_us/approach.html

Although we cant say that Mr Frédéric Boned appeared very "active" wrt Fruitflow.
https://www.provexis.com/about-provexis/board-of-directors/

https://www.linkedin.com/feed/update/activity:6983592876282634240

Frederic Boned our non executive director at DSM is leaving DSM so I wonder if another will be appointed as they still own 6.5% of pxs.

Probably due to the very low volume of buys/sells.

https://pbs.twimg.com/media/FeIEorFaYAAoHxa?format=jpg&name=medium

Seems like its due to platelet factor 4.

Another reason to take FF as it decreases PF4
https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-022-03558-5#:~:text=Fruitflow%20decreased%20PF4%20levels%20in,including%20vascular%20inflammation%20and%20atherosclerosis.

"not signed a major name" I suppose you mean other than By-Health who is a "global leader in the VDS industry"
https://www.by-health.com/en/aboutus/

"To think that at one point Unilever and CC were interested and the company lost their interest because of a lack of willingness to grant exclusivity"
Not strictly true as both had exclusivity in there area.
14 November 2007
Provexis and Unilever renew Fruitflow(R) Exclusivity Agreement
https://www.investegate.co.uk/provexis-plc/rns/collaboration-renewal/200711140700496544H/

15 November 2007
EXCLUSIVE FRUITFLOW(R) TECHNOLOGY ASSESSMENT AGREEMENT WITH THE COCA-COLA
COMPANY
https://www.investegate.co.uk/provexis-plc/rns/re-agreement/200711160700058581H/

JSL.

Yes wellsite, its been popping up quite a lot in the internet but its good that it came directly from the By-Health website as we don't get a lot of good info from them.

"The discovery of this new mechanism further unveils the mystery of Qingluoxin" (fruitflow), "and provides more new ideas for its functional transformation and product landing. With the deepening of scientific research, it is expected to bring more health products with scientific and technological content to the public in the future"

May be taking longer than we first thought but the end result should be good.

Great writeup in the Enterprise News section of By-Healths website.

https://www.by-health.com/news-4588

and they keep popping up.
https://k-sina-com-cn.translate.goog/article_1664221137_6331ffd1020016hyc.html?_x_tr_sch=http&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp#/

https://www-sohu-com.translate.goog/a/587650785_121118802?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

https://www-163-com.translate.goog/dy/article/HHVKDDD90548OE0Z.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

Chinese articles
The "cardiovascular health guard" in tomato - Qingluosu, the latest research by BY-HEALTH reveals its new mechanism
https://www-sohu-com.translate.goog/a/587331025_100199396?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

Think this might have been posted before but dated yesterday.
The old articles seem to pop up on a regular basis.
https://www-163-com.translate.goog/dy/article/HHSSAGUS05532JVW.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

DSM patent.
Not read this so not sure why Fruitflow gets a mention in this new patent from DSM.
COMPUTER-BASED METHOD FOR DESIGNING NUTRITIONAL VALUABLE MEAT AND FISH ALTERNATIVES BASED ON NON-ANIMAL PROTEINS, COMPUTER PROGRAM PRODUCT FOR IT, NUTRITIONAL VALUABLE MEAT AND FISH ALTERNATIVES AND THEIR MANUFACTURE
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022194786&_cid=P10-L8E0EB-56467-1

Very keen on getting some info on this as well although it could be a long way off.
At the very least it would be good to know what area the drug would target.

Pure speculation but could it be..........
COMPOSITION WITH EFFECT OF ASSISTING IN REDUCING BLOOD FAT

"?Experimental studies accidentally found that the water-soluble tomato concentrate and the functional red yeast powder have a coordinated synergistic effect in the aspect of assisting in reducing blood fat, and the two are compounded, so that the levels of triglyceride, cholesterol and low-density lipoprotein can be obviously reduced, thereby achieving an excellent effect of assisting in reducing blood fat."

https://patentscope.wipo.int/search/en/detail.jsf?docId=CN362207783&_cid=P10-L8DCEM-22132-1

Wellsite, it's all pretty complex but if you want to make a health claim it has to be on the register.

https://www.asa.org.uk/advice-online/food-health-claims.html

Hi Sirrom, Its never nice to be sitting on a paper loss on any share.
There are no guarantees when investing in a company but in my opinion 1.2p is not unachievable. News on By-Health or Provexis announcing a profit could easily see the sp much higher than were it is at the moment.

everhopeful, you said previously "I find it amazing that people just have one investment interest"

Well, I find it even more amazing that people are invested in a company that they thing so little about.

https://www-toutiao-com.translate.goog/article/7140926277506073100/?log_from=cb6477ad0823e_1662745666134&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp&wid=1662745925715

We have already been told.
"The Company expects to report total revenue for the year of £426k and an underlying operating loss of £173k. The expected £173k underlying operating loss for the year is 23% ahead of the prior year (2021: an underlying operating loss of £225k) and is an all-time low number for the business."

Next years results should see 3 months of increased revenue due to the new agreement with DSM and hopefully something from By-Health.

DP64,
RE: "where else do you post?"
I don't. I only post on this board (LSE Provexis Share Chat) and very, very occasionally on the ADVFN Provexis chat board.
As for my other investments. I would rather keep that to myself.